Literature DB >> 22411522

Guidelines for specialized nutritional and metabolic support in the critically-ill patient: update. Consensus SEMICYUC-SENPE: critically-ill burnt patient.

A García de Lorenzo y Mateos1, C Ortiz Leyba, S M Sánchez.   

Abstract

The response to severe burns is characterized by hypermetabolism (the most hypermetabolic existing model of aggression) and hypercatabolism, with a high degree of destruction of the skeletal musculature. Metabolic disorders are most evident in the first two weeks after the burn, although they can be prolonged in direct relation to the complications that these patients develop. Nutritional-metabolic support is an essential part of the treatment of these patients and should be started early, preferentially through the enteral route, with parenteral nutrition as complementary support. Exact calculation of calorie-protein requirements in these patients is difficult, even when indirect calorimetry is used, due to the high loss of proteins and CO2 through the skin. Specific pharmaconutrients are indicated, with a high dose of micronutrients. The use of drugs or medications with anabolic effects is also sometimes indicated.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22411522     DOI: 10.1590/S0212-16112011000800013

Source DB:  PubMed          Journal:  Nutr Hosp        ISSN: 0212-1611            Impact factor:   1.057


  3 in total

Review 1.  Impact of Soluble Fiber in the Microbiome and Outcomes in Critically Ill Patients.

Authors:  Carla Venegas-Borsellino; Minkyung Kwon
Journal:  Curr Nutr Rep       Date:  2019-12

2.  Proteasome Inhibition After Burn Injury.

Authors:  P Geoff Vana; Heather M LaPorte; Yee M Wong; Richard H Kennedy; Richard L Gamelli; Matthias Majetschak
Journal:  J Burn Care Res       Date:  2016 Jul-Aug       Impact factor: 1.845

3.  Activities of nonlysosomal proteolytic systems in skeletal and cardiac muscle during burn-induced hypermetabolism.

Authors:  Yee M Wong; Heather M La Porte; Andrea Szilagyi; Harold H Bach; Li Ke-He; Richard H Kennedy; Richard L Gamelli; Ravi Shankar; Matthias Majetschak
Journal:  J Burn Care Res       Date:  2014 Jul-Aug       Impact factor: 1.845

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.